EFFECT OF CO-TRIMOXAZOLE ON RENAL CREATININE EXCRETION IN MAN

被引:9
|
作者
BRAUTIGAM, M
FROESE, P
BAETHKE, R
KESSEL, M
机构
[1] Abteilung für Innere Medizin mit Schwerpunkt Nephrologie Klinikum Charlottenburg, der Freien Universität Berlin, Berlin 19, D-1000
来源
KLINISCHE WOCHENSCHRIFT | 1979年 / 57卷 / 02期
关键词
Co-trimoxazole; Endogenous creatinine clearance; Inulin clearance;
D O I
10.1007/BF01491342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical observations have shown, that administration of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) may result in an elevation of the serum-creatinine level. In 27 subjects the endogenous creatinine- and inulinclearance were measured before and during oral or parenteral application of Co-trimoxazole. The inulinclearance showed no significant differences (p>0,05). But the endogenous creatinine clearance showed a reduction of 18% during the oral and of 13% during the parenteral treatment (p≦0,05) These observations indicate a functional inhibition of the tubular creatinine secretion by Co-trimoxazole. © 1979 Springer-Verlag.
引用
收藏
页码:95 / 96
页数:2
相关论文
共 50 条
  • [31] Evaluation of Weight-Based Co-trimoxazole Dosing in a Saudi Tertiary Hospital
    Alshehri, Samah
    Alghuraybi, Rawan
    Ayoub, Elaf
    Bokhary, Jomana
    Lashkar, Manar
    Alshibani, Mohannad
    Eljaaly, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [32] Malaria, sickle cell disease, HIV, and co-trimoxazole prophylaxis: An observational study
    Owusu, Ewurama D. A.
    Cofie, Nana S. A.
    Nai, Edna A.
    Klipstein-Grobusch, Kerstin
    Brown, Charles A.
    Mens, Petra F.
    Grobusch, Martin P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 69 : 29 - 34
  • [33] The role of oral co-trimoxazole in treating Nocardia farcinica keratitis—a case report
    Neharika Sharma
    Stephen O’Hagan
    Journal of Ophthalmic Inflammation and Infection, 6 (1)
  • [34] Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction
    Tom Schalekamp
    Johanna H. H. van Geest-Daalderop
    Mark H. H. Kramer
    Angelique T. M. van Holten-Verzantvoort
    Anthonius de Boer
    European Journal of Clinical Pharmacology, 2007, 63 : 335 - 343
  • [35] Azithromycin and Co-Trimoxazole in Antimicrobial Prophylaxis: Special Emphasis on Primary Immunodeficiencies in Children
    Boyarchuk, Oksana
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 (03): : 530 - 538
  • [36] Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction
    Schalekamp, Tom
    van Geest-Daalderop, Johanna H. H.
    Kramer, Mark H. H.
    van Holten-Verzantvoort, Angelique T. M.
    de Boer, Anthonius
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (04) : 335 - 343
  • [37] Gastrointestinal damage induced by cytostatic treatment does not affect the bioavailability of co-trimoxazole
    Nyhlén, A
    Johnsson, A
    Höglund, P
    Ljungberg, B
    Nilsson-Ehle, I
    CHEMOTHERAPY, 1999, 45 (06) : 399 - 404
  • [38] The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report
    Neharika Sharma
    Stephen O’Hagan
    Journal of Ophthalmic Inflammation and Infection, 6 (1)
  • [39] The role of oral co-trimoxazole in treating Nocardia farcinica keratitis-a case report
    Sharma, Neharika
    O'Hagan, Stephen
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2016, 6
  • [40] Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children
    Omar, SA
    Bakari, A
    Owiti, A
    Adagu, IS
    Warhurst, DC
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (06) : 657 - 660